טוען...
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most frequent primary liver tumor. As a result of advanced disease being often present at diagnosis, only a small percentage of patients are amenable to curative-intent treatment options such as surgical resection and liver transplantation. Systemic therapy cons...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2022-04-01
|
| סדרה: | Cancers |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2072-6694/14/8/2018 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|